Peritoneal Carcinoma: Clinical Trials

3 trials for Peritoneal Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 terminated, 1 withdrawn. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Active not recruiting 1, Terminated 1, Withdrawn 1

Follow Peritoneal Carcinoma: new trials by email Literature Review of Peritoneal Carcinoma trials Research Report on Peritoneal Carcinoma

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
DCVAC/OvCa and Standard of Care (SoC) in Relapsed Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma
DCVAC/OvCa, DCVAC/OvCa placebo - Ovarian Cancer, Fallopian Tube Cancer
Phase 3WithdrawnSOTIO a.s.2021-08-012021-12-23
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery
Oregovomab, Paclitaxel, Carboplatin - Carcinoma, Ovarian Epithelial, Ovarian Neoplasms
Phase 3Active not recruitingCanariaBio Inc.6152020-08-252026-04-01
Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer
Interferon gamma-1b - Ovarian Carcinoma, Peritoneal Carcinoma
Phase 3TerminatedInterMune8472001-10-012007-11-01

Narrower conditions

Ovarian Neoplasms (3)  ·  Fallopian Tube Neoplasms (2)  ·  Carcinoma (1)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Neoplasms (1)  ·  Peritoneal Neoplasms (1)

Broader conditions

Adnexal Diseases (3)  ·  Endocrine Gland Neoplasms (3)  ·  Endocrine System Diseases (3)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Genital Diseases (3)  ·  Genital Diseases, Female (3)  ·  Genital Neoplasms, Female (3)  ·  Gonadal Disorders (3)  ·  Neoplasms by Site (3)  ·  Ovarian Diseases (3)  ·  Urogenital Diseases (3)  ·  Urogenital Neoplasms (3)  ·  Fallopian Tube Diseases (2)  ·  Neoplasms (2)

Interventions

Carboplatin (1)  ·  Paclitaxel (1)  ·  interferon gamma-1b (1)  ·  oregovomab (1)

Sponsors

CanariaBio Inc. (1)  ·  InterMune (1)  ·  SOTIO a.s. (1)

Countries

United States (2)  ·  Argentina (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  Chile (1)  ·  Czechia (1)  ·  Hungary (1)  ·  India (1)  ·  Italy (1)  ·  Mexico (1)  ·  South Korea (1)  ·  Spain (1)  ·  Taiwan (1)

Top investigators

David Cibula, Prof. MD PhD (1)  ·  Harald Fricke, MD PhD (1)  ·  Sunil Gupta, MD, FRCPC (1)